Why it was recalled
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Product description
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.
Lot numbers, UPCs & expiration codes
Lots: P0001178 Exp. 05/2023; P0001298, P0001301, P0001313, P0001314, P0001317 Exp. 08/2023; P0001330, P0001464 Exp. 09/2023; P0001442 Exp. 11/2023; P0001467, P0001472, P0001486, P0001532 Exp. 12/2023.
Where it was sold
Nationwide within the United States
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0079-2023
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- Nov 28, 2022
- FDA report date
- Dec 21, 2022
- Quantity
- 489,600 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Exela Pharma Sciences LLC
Original FDA data
Every field from FDA enforcement report D-0079-2023, exactly as published.
Show all FDA fields
- City
- Lenoir
- State
- NC
- Status
- Terminated
- Country
- United States
- Event ID
- 91197
- Address
- 1245 Blowing Rock Blvd
- Code information
- Lots: P0001178 Exp. 05/2023; P0001298, P0001301, P0001313, P0001314, P0001317 Exp. 08/2023; P0001330, P0001464 Exp. 09/2023; P0001442 Exp. 11/2023; P0001467, P0001472, P0001486, P0001532 Exp. 12/2023.
- Postal code
- 28645-3618
- Report date
- Dec 21, 2022
- Product type
- Drugs
- Recall number
- D-0079-2023
- Classification
- Class I
- Recalling firm
- Exela Pharma Sciences LLC
- Product quantity
- 489,600 vials
- Termination date
- Oct 10, 2025
- Reason for recall
- Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.
- Distribution pattern
- Nationwide within the United States
- Recall initiation date
- Nov 28, 2022
- Initial firm notification
- Press Release
- Center classification date
- Dec 13, 2022